Cancer Statistics Section - Fast Stats. Surveilane Epidemiology and End Results Web site. Available at: www.seer.cancer.gov/faststats. Accessed January 15 2011.
SturgisEMCinciripiniPM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of HPV associated cancers?Cancer2007;110:1429–1435.
CarvalhoALNishimotoINCalifanoJAKowalskiLP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer2005;114:806–816.
ChaturvediAKEngelsEAAndersonWFGillisonML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the united states. J Clin Oncol2008;26:612–619.
SchwartzSMDalingJRDoodyDR. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst1998;90:1626–1636.
GillisonMLKochWMCaponeRB. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst2000;92:709–720.
MorkJLieAKGlattreE. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med2001;344:1125–1131.
GillisonMLD’SouzaGWestraW. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst2008;100:407–420.
SmithEMRitchieJMSummersgillKF. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst2004;96:449–455.
KreimerARCliffordGMBoylePFranceschiS. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev2005;14:467–475.
HobbsCGSterneJABaileyM. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol2006;31:259–266.
ErnsterJASciottoCGO’BrienMM. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope2007;117:2115–2128.
JiXNeumannASSturgisEM. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis2008;29:875–879.
NäsmanAAttnerPHammarstedtL. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?Int J Cancer2009;125:362–366.
HongAMGrulichAEJonesD. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine2010;28:3269–3272.
D’SouzaGZhangHHD’SouzaWD. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol2010;46:100–104.
GuanXSturgisEMLeiD. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res2010;16:1416–1422.
SettleKPosnerMRSchumakerLM. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila)2009;2:776–781.
DahlstromKRLiGTortolero-LunaG. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neckin press.
HeckJEBerthillerJVaccarellaS. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol2010;39:166–181.
MarurSD’SouzaGWestraWHForastiereAA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol2010;11:781–789.
MorkJMøllerBDahlTBrayF. Time trends in pharyngeal cancer incidence in Norway 1981-2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control2010;21:1397–1405.
AuluckAHislopGBajdikC. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer2010;116:2635–2644.
MehtaVYuGPSchantzSP. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope2010;120:2203–2212.
AttnerPDuJNäsmanA. The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer2010;126:2879–2884.
Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep2010;59:630–632.
ChenLMLiGReitzelLR. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila)2009;2:782–791.
RaginCCTaioliE. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer2007;121:1813–1820.
FakhryCWestraWHLiS. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst2008;100:261–269.
RischinDYoungRJFisherR. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol2010;28:4142–4148.
LassenPEriksenJGHamilton-DutoitS. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol2010;94:30–35.
SinghiADWestraWH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer2010;116:2166–2173.
BraakhuisBJBrakenhoffRHMeijerCJ. Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance. Eur J Cancer2009;45:2935–2939.
PytyniaKBGrantJREtzelCJ. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol2004;22:3981–3988.
WordenFPKumarBLeeJS. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol2008;26:3138–3146.
KumarBCordellKGLeeJS. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol2008;26:3128–3137.
WeinbergerPMYuZHafftyBG. Molecular classification identifies a subset of human papillomavirus—associated oropharyngeal cancers with favorable prognosis. J Clin Oncol2006;24:736–747.
LicitraLPerroneFBossiP. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol2006;24:5630–5636.
PignonJPMaître AlMaillardEBourhisJ. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol2009;92:4–14.
BonnerJAHarariPMGiraltJ. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med2006;354:567–578.
PosnerMRHershockDMBlajmanCR. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med2007;357:1705–1715.
VermorkenJBRemenarEvan HerpenC. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med2007;357:1695–1704.
CooperJSPajakTFForastiereAA. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New Engl J Med2004;350:1937–1944.
BernierJDomengeCOzsahinM. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New Engl J Med2004;350:1945–1952.
GardenASAsperJAMorrisonWH. Is concurrent chemoradiation the treatment of choice for all patients with stage III or IV head and neck carcinoma?Cancer2004;100:1171–1178.
EisbruchAHarrisJGardenAS. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys2010;76:1333–1338.
BonnerJAHarariPMGiraltJ. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol2010;11:21–28.
ZafereoMEHanasonoMMRosenthalDI. The role of salvage surgery in recurrent oropharyngeal squamous cell carcinoma. Cancer2009;115:5723–5733.
CohenMAWeinsteinGSO’MalleyBWJr. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck2011;33:573–580.